五积散治疗韩国女性手足冷过敏的随机双盲安慰剂对照多中心预试验方案
本研究为多中心、双盲、随机、安慰剂对照、两臂平行预试验,计划纳入60名韩国女性手足冷过敏患者,按1:1随机分入五积散组或安慰剂组,每日服药3次、持续8周。主要结局为手足冷视觉模拟量表评分从基线至第8周的平均变化,次要结局包括四肢皮肤温度、冷应激后手部皮肤温度恢复率及WHO生活质量量表简版韩国版评分,旨在为后续大规模随机对照试验提供依据。
要点
- 五积散组与安慰剂组按1:1随机,每日3次、疗程8周。
- 主要结局为手部冷过敏视觉模拟量表评分第8周较基线的平均变化。
- 次要结局含四肢皮肤温度、冷应激后手温恢复率及生活质量评分。
核心结论
- 本预试验旨在评估五积散治疗韩国女性手足冷过敏的安全性、有效性及开展完整随机临床试验的可行性。
研究设计与样本
- 多中心、双盲、随机、安慰剂对照、两臂平行预试验,计划纳入60名参与者,按1:1比例经互联网随机系统分组。
- 每组分别给予五积散或安慰剂,每日3次,持续8周。
关键数值与推荐
- 主要结局为手部冷过敏视觉模拟量表评分从基线至第8周的平均变化。
- 次要结局包括四肢皮肤温度平均变化、冷应激试验后手部皮肤温度恢复率及WHO生活质量量表简版韩国版评分。
临床怎么用
- 研究结果预期为后续大规模随机对照试验确认五积散对女性手足冷过敏的安全性和有效性提供参考信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to evaluate the safety, efficacy, and feasibility of a full randomized clinical trial of Ojeok-san in Korean female patients with cold hypersensitivity in the hands and feet. METHODS: This study is a multicenter, double-blinded, randomized, placebo-controlled, two-arm, parallel-group pilot clinical trial. A total of 60 participants will be enrolled and randomly assigned to the Ojeok-san treatment group or the placebo control group, in a 1:1 ratio using an Internet-based randomization system. Each group will be administered Ojeok-san or placebo three times per day for 8 weeks. The primary outcome will be the mean change in the Visual Analog Scale scores of cold hypersensitivity in the hands from baseline to week 8. Secondary outcomes will include the mean changes in the skin temperature of the extremities, recovery rate of the skin temperature of hands after cold stress test, and the score of Korean version of the WHO Quality of Life Scale abbreviated version. DISCUSSION: The findings of this study should provide meaningful information for a further large-scale, randomized controlled trial to confirm the safety and efficacy of Ojeok-san on cold hypersensitivity in the hands and feet in female patients. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03083522 . Registered on 20 March 2017.
引用
- Ko Y, Go HY, Han IS, et al. Efficacy and safety of Ojeok-san in Korean female patients with cold hypersensitivity in the hands and feet: study protocol for a randomized, double-blinded, placebo-controlled, multicenter pilot study. Trials. 2018. PMID: 30497488. doi:10.1186/s13063-018-3013-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。